HIGHLIGHTS
- who: Na Song and collaborators from the Department of Medical Oncology, the First Hospital of China Medical University, Shenyang , have published the research work: Cetuximab-Induced MET Activation Acts as a Novel Resistance Mechanism in Colon Cancer Cells, in the Journal: (JOURNAL)
- what: The authors demonstrated that MET activation induced by cetuximab was involved in resistance to cetuximab in colon cancer cells.
- how: These results indicated that the mutual interaction between MET and SRC was strongly linked in the process of MET activation thus inhibition of SRC enhanced cetuximab sensitivity through suppressing MET . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.